跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Irimed - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Irimed
Approved
STANDARD
Irimed
Korea United Pharm. Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
6a89e42e154ec26d
Company
Korea United Pharm. Inc.
Type
Standard
Approval Details
Approval Id
6a89e42e154ec26d
Drug Approval Philippines Name
Irimed
Product Name
Irimed
Registration Number
DRP-16650
Brand Name
Irimed
Generic Name
Irinotecan HC1
Dosage Form
Solution for Injection (IV)
Dosage Strength
20 mg/mL (100 mg/5 mL)
Manufacturer
Korea United Pharm. Inc.
Importer
Qualimed Pharma Inc.
Distributor
Qualimed Pharma Inc.
Company Detail Path
/organization/korea-united-pharm-inc
Issuance Date
28 May 2025
Expiry Date
28 May 2030
Pharmacologic Category
Antineoplastic (Cell Cycle-Specific Agent)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
6a89e42e154ec26d
Type
Standard
Back to Philippines FDA Approvals